Skip to main content

Animations

MJFF Publications

1081 - 1090 of 6467 Results
Title
Year
  • Year
  • 2012
  • 2012
  • 2014
  • 2009
  • 2008
  • 2010
  • 2014
  • 2010
  • 2010
  • 2013
  • Summary Details
    OPEN
    Title: Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms2032
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms1669
    Citation Count: 252
  • Summary Details
    OPEN
    Title: Archaerhodopsin variants with enhanced voltage-sensitive fluorescence in mammalian and Caenorhabditis elegans neurons
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms5894
    Citation Count: 144
  • Summary Details
    OPEN
    Title: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.300
    Best OA location URL: http://doi.org/10.1038/ng.300
    Citation Count: 537
  • Summary Details
    OPEN
    Title: Therapeutic cloning in individual parkinsonian mice
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm1732
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm.2199
    Citation Count: 382
  • Summary Details
    OPEN
    Title: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms4633
    Citation Count: 334
  • Summary Details
    OPEN
    Title: HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.2692
    Citation Count: 183
  • Summary Details
    OPEN
    Title: Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.642
    Citation Count: 810
  • Summary Details
    OPEN
    Title: CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3353
    Citation Count: 82
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.